Emmanuel Puginier
Chief Operating Officer at Novartis Pharma KK
Profile
Emmanuel Puginier was a Director of Idenix Pharmaceuticals, Inc. from November 2007 to February 3, 2009.
He has served as Global Head of Marketing and Sales General Medicine for Novartis Pharma AG since July 2007.
Dr. Puginier has held several positions with Novartis AG, including Chief Operating Officer of Novartis Pharma Japan, Chief Executive Officer of Novartis Pharma Germany and Regional Head-Europe, Middle East and Africa since 1992.
Prior to joining Novartis, he worked as a Physician in France.
Dr. Puginier received an MD from Paul Sabatier University, France.
Emmanuel Puginier active positions
| Companies | Position | Start |
|---|---|---|
Novartis Pharma KK
 Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan. | Chief Operating Officer | 31/12/1991 |
Former positions of Emmanuel Puginier
| Companies | Position | End |
|---|---|---|
| IDENIX PHARMACEUTICALS INC | Director/Board Member | 02/02/2009 |
| Novartis Pharma Germany | President | - |
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Sales & Marketing | - |
Training of Emmanuel Puginier
| Université Toulouse III - Paul Sabatier | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Commercial Services |
Novartis Pharma KK
Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan. | Health Technology |
| Novartis Pharma Germany |
- Stock Market
- Insiders
- Emmanuel Puginier
